COATS LONNEL
Insider CIK 1612528 · LXRX President and CEO, Director · BPMC Director · RLAY Director · VERV Director · MLYS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-10-19 | 2026-10-20 | 16,600 | — | $0 | 16,600 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-10-19 | 2026-10-20 | 12,400 | — | $0 | 12,400 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 32,947 | — | $0 | 32,947 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 207,931 | — | $0 | 207,931 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 42,200 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 136,139 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 3,188 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,875 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 10,909 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 10,909 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 11,818 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer | 2025-07-17 | 2025-07-21 | 6,144 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $12812.00 | $49.99M | 6,144 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 42,200 | — | $0 | 42,200 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-11-21 | 2024-11-22 | 9,824 | $94.87 | $932.0K | 2,242 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-11-20 | 2024-11-22 | 1,312 | — | $0 | 3,188 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-11-20 | 2024-11-22 | 7,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-11-20 | 2024-11-22 | 4,500 | $93.15 | $419.2K | 17,566 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-11-20 | 2024-11-22 | 213 | $94.99 | $20.2K | 12,066 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-11-20 | 2024-11-22 | 5,287 | $94.24 | $498.2K | 12,279 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-11-20 | 2024-11-22 | 1,312 | $76.24 | $100.0K | 22,066 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-11-20 | 2024-11-22 | 7,500 | $69.79 | $523.4K | 20,754 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 136,139 | — | $0 | 136,139 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-06-12 | 2024-06-14 | 4,570 | — | $0 | 4,570 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-06-12 | 2024-06-14 | 2,242 | — | $0 | 13,254 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 120,383 | — | $0 | 240,767 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 91,364 | — | $0 | 91,363 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 33,333 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 33,333 | — | $0 | 947,692 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 91,364 | — | $0 | 1,039,056 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2024-02-28 | 2024-02-29 | 61,371 | $2.62 | $160.8K | 1,098,068 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 120,383 | — | $0 | 1,159,439 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 770,420 | — | $0 | 770,420 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 770,420 | — | $0 | 770,420 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-11-16 | 2023-11-17 | 90,000 | $1.05 | $94.5K | 914,359 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-11-10 | 2023-11-13 | 10,000 | $1.01 | $10.1K | 824,359 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-06-29 | 2023-06-29 | 10,000 | $2.16 | $21.6K | 814,359 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-06-26 | 2023-06-26 | 10,000 | $2.18 | $21.8K | 804,359 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-06-23 | 2023-06-26 | 10,000 | $2.50 | $25.0K | 794,359 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-06-22 | 2023-06-22 | 40,000 | $2.31 | $92.4K | 784,359 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-06-21 | 2023-06-23 | 0 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-06-21 | 2023-06-23 | 2,600 | — | $0 | 11,012 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 26,642 | — | $0 | 26,642 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 33,334 | — | $0 | 33,333 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 91,363 | — | $0 | 182,727 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 84,630 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 91,363 | — | $0 | 795,330 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 84,630 | — | $0 | 670,633 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 33,334 | — | $0 | 703,967 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2023-02-28 | 2023-03-01 | 50,971 | $2.17 | $110.6K | 744,359 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 1,083,440 | — | $0 | 1,083,440 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 361,150 | — | $0 | 361,150 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2022-08-08 | 2022-08-09 | 31,000 | — | $0 | 31,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2022-06-21 | 2022-06-30 | 5,300 | — | $0 | 5,300 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2022-06-21 | 2022-06-30 | 2,600 | — | $0 | 8,412 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 84,630 | — | $0 | 84,630 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 33,333 | — | $0 | 66,667 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 79,380 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 79,380 | — | $0 | 516,093 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 84,630 | — | $0 | 600,723 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2022-02-28 | 2022-02-28 | 48,053 | $2.85 | $137.0K | 586,003 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 33,333 | — | $0 | 634,056 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 822,280 | — | $0 | 822,280 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 274,090 | — | $0 | 274,090 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2021-06-02 | 2021-06-04 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2021-06-02 | 2021-06-04 | 2,250 | — | $0 | 5,812 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 84,630 | — | $0 | 169,260 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 5,362 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 23,513 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 79,380 | — | $0 | 79,380 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 5,362 | — | $0 | 304,228 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2021-02-28 | 2021-03-02 | 55,038 | $7.19 | $395.7K | 436,713 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 84,630 | — | $0 | 491,751 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 79,380 | — | $0 | 407,121 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 23,513 | — | $0 | 327,741 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 300,000 | — | $0 | 300,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2020-06-24 | 2020-06-26 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2020-06-24 | 2020-06-26 | 2,250 | — | $0 | 3,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-06-19 | 2020-06-23 | 1,312 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-06-19 | 2020-06-23 | 1,312 | — | $0 | 1,312 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 8,390 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 5,363 | — | $0 | 5,362 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 79,380 | — | $0 | 158,760 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 23,514 | — | $0 | 23,513 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 5,363 | — | $0 | 241,292 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 8,390 | — | $0 | 235,929 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 23,514 | — | $0 | 264,806 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-02-28 | 2020-03-03 | 45,320 | $2.77 | $125.5K | 298,866 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 79,380 | — | $0 | 344,186 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 253,890 | — | $0 | 253,890 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 761,660 | — | $0 | 761,660 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-09-18 | 2019-09-19 | 50,000 | $3.10 | $155.0K | 227,539 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-09-17 | 2019-09-18 | 40,290 | $3.13 | $126.1K | 177,539 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-09-17 | 2019-09-18 | 277 | $3.13 | $867 | 137,249 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-09-17 | 2019-09-18 | 6,333 | $3.12 | $19.8K | 136,972 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-09-17 | 2019-09-18 | 3,000 | $3.12 | $9.4K | 130,639 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-09-17 | 2019-09-18 | 100 | $3.13 | $313 | 127,639 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-08-19 | 2019-08-20 | 3,000 | $1.40 | $4.2K | 127,539 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-08-16 | 2019-08-20 | 600 | $1.35 | $810 | 105,039 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-08-16 | 2019-08-20 | 6,600 | $1.34 | $8.8K | 104,439 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-08-16 | 2019-08-20 | 3,500 | $1.35 | $4.7K | 108,539 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-08-16 | 2019-08-20 | 16,000 | $1.36 | $21.8K | 124,539 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-08-16 | 2019-08-20 | 156 | $1.33 | $207 | 87,695 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-08-16 | 2019-08-20 | 10,044 | $1.33 | $13.4K | 97,739 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-08-16 | 2019-08-20 | 100 | $1.34 | $134 | 97,839 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-08-15 | 2019-08-19 | 10,000 | — | $0 | 11,818 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-08-15 | 2019-08-19 | 10,000 | $15.01 | $150.1K | 10,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-08-15 | 2019-08-19 | 2,702 | $83.57 | $225.8K | 7,298 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-08-15 | 2019-08-19 | 3,098 | $82.48 | $255.5K | 4,200 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-08-15 | 2019-08-19 | 4,200 | $81.59 | $342.7K | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-06-19 | 2019-06-20 | 1,312 | — | $0 | 1,312 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-06-19 | 2019-06-20 | 4,875 | — | $0 | 4,875 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 5,363 | — | $0 | 10,725 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 10,835 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 8,390 | — | $0 | 8,390 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 23,513 | — | $0 | 47,027 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 5,363 | — | $0 | 82,667 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 23,513 | — | $0 | 106,180 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 10,835 | — | $0 | 68,914 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 8,390 | — | $0 | 77,304 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2019-02-28 | 2019-03-01 | 18,641 | $5.51 | $102.7K | 87,539 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 442,260 | — | $0 | 442,260 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 238,140 | — | $0 | 238,140 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2018-06-21 | 2018-06-25 | 7,500 | — | $0 | 51,136 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 5,362 | — | $0 | 16,088 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 8,390 | — | $0 | 16,780 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 10,836 | — | $0 | 10,835 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 10,836 | — | $0 | 53,821 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 5,362 | — | $0 | 67,573 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2018-02-28 | 2018-03-02 | 9,494 | $8.53 | $81.0K | 58,079 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 8,390 | — | $0 | 62,211 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 70,540 | — | $0 | 70,540 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 211,610 | — | $0 | 211,610 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-11-15 | 2017-11-15 | 10,000 | $9.91 | $99.1K | 42,985 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 194 | $12.51 | $2.4K | 28,779 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 149 | $12.57 | $1.9K | 28,585 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 1,200 | $12.58 | $15.1K | 28,436 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 300 | $12.55 | $3.8K | 27,236 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 600 | $12.52 | $7.5K | 26,936 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 2,000 | $12.57 | $25.1K | 26,336 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 1,951 | $12.56 | $24.5K | 24,336 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 2,400 | $12.55 | $30.1K | 22,385 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 306 | $12.54 | $3.8K | 30,785 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 300 | $12.58 | $3.8K | 31,085 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 300 | $12.65 | $3.8K | 31,385 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 1,200 | $12.52 | $15.0K | 30,479 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 300 | $12.62 | $3.8K | 32,285 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 400 | $12.54 | $5.0K | 19,985 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 4,253 | $12.53 | $53.3K | 19,585 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 3,247 | $12.54 | $40.7K | 15,332 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 5,200 | $12.54 | $65.2K | 12,085 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 3,300 | $12.52 | $41.3K | 6,885 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 300 | $12.49 | $3.7K | 3,585 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 300 | $12.49 | $3.7K | 3,285 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 400 | $12.64 | $5.1K | 32,985 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 300 | $12.62 | $3.8K | 32,585 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 400 | $12.52 | $5.0K | 29,179 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 100 | $12.52 | $1.3K | 29,279 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 600 | $12.62 | $7.6K | 31,985 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2017-06-21 | 2017-06-23 | 10,909 | — | $0 | 43,636 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 8,390 | — | $0 | 25,170 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 10,836 | — | $0 | 21,671 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2017-02-28 | 2017-03-01 | 5,258 | $16.45 | $86.5K | 20,767 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 10,836 | — | $0 | 17,635 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 8,390 | — | $0 | 26,025 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 85,780 | — | $0 | 85,780 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 21,450 | — | $0 | 21,450 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2016-06-23 | 2016-06-27 | 10,909 | — | $0 | 32,727 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 10,835 | — | $0 | 32,507 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 10,835 | — | $0 | 10,835 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2016-02-29 | 2016-03-02 | 4,036 | $9.07 | $36.6K | 6,799 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-02-11 | 2016-02-16 | 134,230 | — | $0 | 134,230 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-02-11 | 2016-02-16 | 33,560 | — | $0 | 33,560 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2016-02-03 | 2016-02-05 | 21,818 | — | $0 | 21,818 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-02-05 | 2015-02-09 | 303,400 | — | $0 | 303,400 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-02-05 | 2015-02-09 | 1,213,600 | — | $0 | 1,213,600 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-07-07 | 2014-07-08 | 853,500 | — | $0 | 853,500 | SEC↗ |